10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32692785 | Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization. | 2020 | 1 |
2 | 30448465 | Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride. | 2019 May 1 | 1 |
3 | 23979838 | Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways. | 2013 Nov | 1 |
4 | 21561378 | Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors. | 2011 Oct | 1 |
5 | 19782075 | Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. | 2010 Jun | 1 |
6 | 20032300 | Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. | 2010 Feb 15 | 2 |
7 | 20617325 | Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. | 2010 Nov | 3 |
8 | 19429119 | Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. | 2009 May 22 | 2 |
9 | 16257959 | GSK-3beta directly phosphorylates and activates MARK2/PAR-1. | 2005 Dec 30 | 2 |
10 | 11602330 | Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules. | 2001 Oct 26 | 1 |